Home/Rio Pharmaceuticals/John Gerdes, Ph.D.

JG

John Gerdes, Ph.D.

President

Rio Pharmaceuticals

Therapeutic Areas

Neurology Oncology

Rio Pharmaceuticals Pipeline

Drug	Indication	Phase
RP115	Alzheimer's Disease	Clinical Trial

Leadership Team at Rio Pharmaceuticals

John Forsayeth, Ph.D.

Executive Chairman

View full Rio Pharmaceuticals profile